Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A 37-year-old woman with autosomal dominant polycystic kidney disease (ADPKD) and normal kidney function, with well-controlled arterial hypertension, and rupture of an intracranial aneurysm at 27 years of age presented to our institute. Ultrasound led to a suspicion of two splenic artery aneurysms, which was subsequently confirmed by computed tomography (Fig. 1). The patient was referred to a vascular surgeon who recommended observation alone. To date, the aneurysms remain clinically silent.
×
ADPKD is the most common monogenic disease of the kidney. It affects approximately 1 in every 1000 people. As well as being a cause of chronic kidney disease, it is accompanied by numerous extra-renal manifestations, including aneurysms. Due to possible dramatic consequences of rupture, intracranial aneurysms, observed in approximately 10% of ADPKD patients [1], attract the most attention. However, aneurysms can also be found in other arteries [2].
Knowledge of the pathogenesis of aneurysms in ADPKD remains piecemeal. ADPKD is caused by a mutation in the PKD1 or PKD2 gene, leading to disturbed structure and function of their protein products, polycystin-1 (PC-1), or polycystin-2 (PC-2), respectively. Mutations in PKD1 or PKD2 lead to dysregulation of various intracellular signaling pathways. Both PKD1 and PKD2 are expressed in the smooth muscle and myofibroblasts of blood vessels, and polycystins play an important role in maintaining the normal structure and function of blood vessels. Additionally, involvement of vascular enothelial growth factor (VEGF), collagen genes and genes of the TGF-β pathway in vascular remodeling was shown; however, exact mechanisms were not elucidated. These changes, together with arterial hypertension, which is common in ADPKD, may result in aneurysm development [S1, S2—see Suppl. file].
Rupture of an intracranial aneurysm in a patient’s medical history is considered a risk factor for the development of new intracranial aneurysms in ADPKD [1]. Our case reminds us that new aneurysms should also be expected in other locations.
Declarations
Conflict of interest
None.
Ethical approval
The manuscript was prepared in accordance with the Declaration of Helsinki. Approval from the institutional board was not required for this case report.
Informed consent
The patient agreed to publication of her data and images in an anonymous form.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.
Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.
Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.
Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.
Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.